Proteomics

Dataset Information

0

Parallelized multidimensional analytic framework applied to mammalian cells uncovers novel regulatory principles in EMT


ABSTRACT: We combine state-of-the-art data acquisition platforms and bioinformatics tools to devise PAMAF, a workflow that simultaneously examines twelve omics modalities, i.e., protein abundance from whole-cells, nucleus, exosomes, secretome and membrane; N-glycosylation, phosphorylation; metabolites; mRNA, miRNA; and, in parallel, single-cell transcriptomes. Here we apply PAMAF in an established in vitro model of TGFβ-induced epithelial to mesenchymal transition (EMT) to quantify >61,000 molecules from 12 omics and 10 timepoints over 12 days. Bioinformatics analysis of this EMT-ExMap resource allowed us to identify; –unexpected topological coupling between omics, –four distinct cell states during EMT (E, E/M-1, E/M-2, M), –omics-specific kinetic paths, –stage-specific multi-omics characteristics, –distinct regulatory classes of genes, –ligand–receptor mediated intercellular crosstalk using an innovative pipeline integrating scRNAseq and subcellular proteomics, and –novel combinatorial drug targets (e.g., Hedgehog signaling and CAMK-II) to inhibit EMT, which we validate using a 3D mammary duct-on-a-chip platform. Overall, while this study provides an unprecedented resource on TGFβ signaling and EMT, PAMAF-like workflows can be applied to generate comprehensive molecular landscapes of other multifaceted biological processes.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Indranil Paul  

LAB HEAD: Andrew Emili

PROVIDER: PXD031071 | Pride | 2022-11-14

REPOSITORIES: Pride

Similar Datasets

2022-11-11 | GSE194008 | GEO
2022-11-11 | GSE193985 | GEO
2022-11-11 | GSE200981 | GEO
2023-12-13 | MODEL2208050002 | BioModels
2014-03-12 | E-GEOD-55710 | biostudies-arrayexpress
2011-05-26 | E-GEOD-28448 | biostudies-arrayexpress
2011-05-26 | GSE28448 | GEO
2023-10-01 | GSE243320 | GEO
2022-06-22 | GSE178575 | GEO
2019-08-26 | PXD014736 | Pride